Clinical study
Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction

Presented, in part, at the 32nd and 33rd Annual Meetings of the American Society of Nephrology in Miami, Florida, November 5 to 8, 1999, and Toronto, Canada, October 13 to 16, 2000, respectively.
https://doi.org/10.1016/S0735-1097(01)01470-XGet rights and content
Under an Elsevier user license
open archive

Abstract

OBJECTIVES

We sought to evaluate the relationship between the level of kidney function, level of hematocrit and their interaction on all-cause mortality in patients with left ventricular (LV) dysfunction.

BACKGROUND

Anemia and reduced kidney function occur frequently in patients with heart failure. The level of hematocrit and its relationship with renal function have not been evaluated as risk factors for mortality in patients with LV dysfunction.

METHODS

We retrospectively examined the Studies Of LV Dysfunction (SOLVD) database. Glomerular filtration rate (GFR) was predicted using a recently validated formula. Kaplan-Meier survival analyses were used to compare survival times between groups stratified by level of kidney function (predicted GFR) and hematocrit. Cox proportional-hazards regression was used to explore the relationship of survival time to level of kidney function, hematocrit and their interaction.

RESULTS

Lower GFR and hematocrit were associated with a higher prevalence of traditional cardiovascular risk factors. In univariate analysis, reduced kidney function and lower hematocrit, in men and in women, were risk factors for all-cause mortality (p < 0.001 for both). After adjustment for other factors significant in univariate analysis, a 10 ml/min/1.73 m2lower GFR and a 1% lower hematocrit were associated with a 1.064 (95% CI: 1.033, 1.096) and 1.027 (95% CI: 1.015, 1.038) higher risk for mortality, respectively. At lower GFR and lower hematocrit, the risk was higher (p = 0.022 for the interaction) than that predicted by both factors independently.

CONCLUSIONS

Decreased kidney function and anemia are risk factors for all-cause mortality in patients with LV dysfunction, especially when both are present. These relationships need to be confirmed in additional studies.

Abbreviations

ACE
angiotensin-converting enzyme
ESRD
end-stage renal disease
GFR
glomerular filtration rate
HF
heart failure
LV
left ventricle or left ventricular
MDRD
Modification of Diet in Renal Disease
NYHA
New York Heart Association
SOLVD
Studies Of Left Ventricular Dysfunction

Cited by (0)

Supported by Amgen Inc., Thousand Oaks, California and grants: K23 NIDDK 02904-01, RO1 NIDDK 53869-02 and MO1 RR00054.